WallStreetZenWallStreetZen

NASDAQ: RSLS
Reshape Lifesciences Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Reshape Lifesciences earnings were -$3.5M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest RSLS earnings report on Mar 31, 2025 announced Q1 2025 earnings of $1.5M, down 183.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RSLS reported annual earnings of -$7.1M, with -37.4% growth.

RSLS earnings history

Current Revenue
$7.2M
Current Earnings
-$3.5M
Current Profit Margin
-48.3%

RSLS Return on Equity

Current Company
-251.9%
Current Industry
7.2%
Current Market
31.5%
RSLS's Return on Equity (-251.9%)... subscribe to Premium to read more.
High Return on Equity Performance

RSLS undefined

Current Company
-59.5%
Current Industry
9.2%
RSLS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when RSLS announces earnings.

RSLS undefined

Current Company
-143.64%
Current Industry
9.3%
RSLS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RSLS vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
RSLS-$3.37M-$3.46MN/A-$193.02
BJDX-$6.24M-$20.48MN/A-$290.56
NUWE-$3.93M-$9.85MN/A-$11.22
BBLG-$4.26M-$7.48MN/A-$20.04
NAOV-$5.41M-$5.61MN/A-$15.18
View Top Medical Device Stocks

Reshape Lifesciences Earnings Reports & History FAQ

What were Reshape Lifesciences's earnings last quarter?

On RSLS's earnings call on Invalid Date, Reshape Lifesciences (NASDAQ: RSLS) reported Q1 2025 earnings per share (EPS) of $18.98, up 114.02% year over year. Total RSLS earnings for the quarter were $1.47 million. In the same quarter last year, Reshape Lifesciences's earnings per share (EPS) was -$135.37.

If you're new to stock investing, here's how to buy Reshape Lifesciences stock.

Is Reshape Lifesciences profitable or losing money?

As of the last Reshape Lifesciences earnings report, Reshape Lifesciences is currently losing money. Reshape Lifesciences's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$3.46 million, a 68.28% decrease year over year.

What was RSLS's earnings growth in the past year?

As of Reshape Lifesciences's earnings date in Invalid Date, Reshape Lifesciences's earnings has grown year over year. RSLS earnings in the past year totalled -$3.46 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.